PharmaBoardroom

R&D: Progress & Potential in Hungary

Investments in research and development are on the rise in Hungary, backed up by government initiatives, but the country needs a more unified effort…

Sascha Herzig – President & CEO, ETH Cargo, Puerto…

Since 2001, ETH Cargo has been operating in Puerto Rico, providing international air and ocean freight services, domestic deliveries, US Customs and…

John Moller – CEO & Yooni Kim – Executive…

John Moller, CEO; and Yooni Kim, executive director of Asia operations, for Novotech, share the competitive positioning of Novotech as a full-service…

Jose Viera-Colon – Region Director Caribbean, Allergan

Jose Viera-Colon, Region Director Caribbean for Allergan, highlights the opportunities and obstacles related to leading the company’s commercial…

Christina M. Busmalis of IBM Watson Health

IBM Watson Health’s Director for Global Life Sciences & Go-To Market Leader for Europe & Asia Pacific Christina Busmalis gives her insights…

Hungary’s National Champions Betting on Biosimilars

Hungary’s two largest pharma firms, Egis Pharmaceuticals and Gedeon Richter, are stepping up their biosimilars offering; providing the European…

Biosimilars Work. Why Aren’t They Taking Off in the US?

The AAM’s Chip Davis examines the roadblocks to greater adoption of biosimilar drugs in the USA, and why they need to be removed to potentially save…

Three Basic Truths About the US Healthcare System

AstraZeneca's Rick R. Suarez looks at workable solutions to the challenges facing healthcare in the US and why inter-stakeholder collaboration, rather…

Drug Shortages Hitting Hungary Hard

Like many of its European counterparts, Hungary is suffering from medicine shortages. Vaccines, vitamins, and orphan drugs are some of the most…

Data for Safer Care: AI in Healthcare-Associated Infections

Awareness is growing of the dangers of healthcare-associated infections (HAIs) in Europe, and conversations are beginning to taking place around how…

Hungary: Falling Behind for Innovative Medicines

Hungarian patients currently experience longer wait times and more limited access to subsidised innovative medicines than their neighbours in Bulgaria…

Chinese Pharma’s Latest Race to the Bottom on Pricing

China's roll-out of a 25-province expansion to the 4+7 pilot procurement scheme has seen pharma companies scrambling to cut prices for their drugs…

Tagged with r